Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
89 studies found for:    rivastigmine
Show Display Options
Rank Status Study
21 Completed
Has Results
Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine patch (4.6 mg/day switch to 9.5 mg/day);   Drug: Rivastigmine patch (9.5 mg/day);   Drug: Rivastigmine capsules (6 mg to 12 mg/day)
22 Terminated
Has Results
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Conditions: Multiple Sclerosis;   Cognitive Impairment
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
23 Completed Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine patch
24 Completed Exelon Patch and Combination With Memantine Comparative Trial
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine transdermal patch (Exelon patch), memantine;   Drug: Rivastigmine transdermal patch
25 Completed
Has Results
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 5 cm^2 transdermal patch;   Drug: Rivastigmine 10 cm^2 transdermal patch
26 Completed
Has Results
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
Conditions: Parkinsons Disease With Dementia;   Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
Intervention: Drug: Rivastigmine Patch 9.5 cm2
27 Completed Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.
Condition: Delirium
Intervention: Drug: Rivastigmine patch
28 Completed Rivastigmine Capsules in Patients With Probable Vascular Dementia
Condition: Vascular Dementia
Intervention: Drug: Rivastigmine
29 Completed Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment
Condition: Traumatic Brain Injury
Intervention: Drug: Rivastigmine
30 Recruiting Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
Conditions: Alzheimer Disease;   CVA (Cerebrovascular Accident)
Intervention: Drug: Rivastigmine
31 Completed Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
32 Completed Efficacy of Rivastigmine in Patients With Down Syndrome
Condition: Down Syndrome
Intervention: Drug: Rivastigmine
33 Unknown  Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine
Condition: Alzheimer's Disease
Intervention: Drug: rivastigmine patch
34 Terminated Rivastigmine for Intensive Care Unit (ICU) Delirium
Condition: Delirium
Interventions: Drug: Rivastigmine;   Drug: Placebo
35 Completed Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
36 Completed Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
Conditions: Parkinson's Disease;   Apathy;   no Dementia
Interventions: Drug: rivastigmine;   Drug: placebo
37 Completed Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
38 Terminated Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Condition: Cognitive Symptoms
Intervention: Drug: Rivastigmine
39 Completed An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits
Condition: Traumatic Brain Injury With Persistent Cognitive Deficits
Intervention: Drug: Rivastigmine
40 Completed Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years